QSS
CNMD icon

Quantitative Systematic Strategies’s CONMED CNMD Stock Holding History

Quantitative Systematic Strategies’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,167
Closed -$710K – 82
2021
Q2 		$710K Buy
5,167
+634
+14% +$86.8K 0.25% 143
2021
Q1 		$592K Sell
4,533
-127
-3% -$15.3K 0.09% 336
2020
Q4 		$522K Buy
+4,660
New +$441K 0.07% 381
2020
Q3 		– Sell
-2,884
Closed -$208K – 615
2020
Q2 		$208K Buy
+2,884
New +$201K 0.04% 507
2019
Q3 		– Sell
-4,201
Closed -$359K – 487
2019
Q2 		$359K Buy
+4,201
New +$345K 0.07% 304

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Quantitative Systematic Strategies's CNMD Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of CONMED (CNMD) in Q3 2021, closing a stake of 5,167 shares — an estimated $710K sold.

Quantitative Systematic Strategies first reported a position in CNMD in Q2 2019 and held it in 5 quarters. The position peaked at $710K in Q2 2021. 262 funds tracked by Wall St. Rank hold CNMD as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining CONMED position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 5,167 CONMED shares in Q3 2021, an estimated $710K.
  • Quantitative Systematic Strategies first reported a position in CONMED in Q2 2019 and held it in 5 quarters.
  • Quantitative Systematic Strategies's CONMED position peaked at $710K in Q2 2021.
  • 262 funds tracked by Wall St. Rank held CONMED as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.